We are live on ! Find out more
PAAMCP

Pacific Alternative Asset Management Company (PAAMCO) Portfolio holdings

AUM $913M
1-Year Est. Return 18.29%
This Fund
S&P 500
This Quarter Est. Return
+8.27%
1 Year Est. Return
+18.29%
3 Year Est. Return
+87.23%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$842M
AUM Growth
+$263M
Cap. Flow
+$202M
Cap. Flow %
24.03%
Top 10 Hldgs %
35.4%
Holding
253
New
95
Increased
71
Reduced
28
Closed
59

Top Buys

Rank Stock Value
1
FRX
FOREST LABORATORIES INC
FRX
+$46.2M
2
COV
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
+$22.1M
3
AGN
Allergan Inc
AGN
+$20.3M
4
MEG
Media General, Inc
MEG
+$18.5M
5
CI icon
Cigna
CI
+$14.3M

Top Sells

Rank Stock Value
1
MCK icon
McKesson
MCK
+$12.7M
2
ODP
ODP
ODP
+$8.35M
3
ESRX
Express Scripts Holding Company
ESRX
+$7.6M
4
BAP icon
Credicorp
BAP
+$7.1M
5
C icon
Citigroup
C
+$6.3M

Sector Composition

Rank Sector Weight
1 Healthcare 36.99%
2 Technology 6.14%
3 Communication Services 4.91%
4 Consumer Discretionary 3.45%
5 Financials 3.44%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AMPE
176
PUT
DELISTED
Ampio Pharmaceuticals Inc.
AMPE
$311K 0.04%
+124
New +$253K
SPNC
177
DELISTED
Spectranetics Corp
SPNC
$300K 0.04%
+13,118
New +$304K
OFIX icon
178
Orthofix Medical
OFIX
$414M
$284K 0.03%
7,821
-13,058
-63% -$422K
ATEC icon
179
Alphatec Holdings
ATEC
$1.5B
$269K 0.03%
13,777
-1,395
-9% -$23.4K
CRNT icon
180
CALL
Ceragon Networks
CRNT
$199M
$264K 0.03%
103,800
+45,800
+79% +$117K
PFE icon
181
Pfizer
PFE
$153B
$227K 0.03%
8,075
-25,834
-76% -$736K
IONS icon
182
Ionis Pharmaceuticals
IONS
$9.28B
$213K 0.03%
+6,190
New +$195K
AMSG
183
DELISTED
Amsurg Corp
AMSG
$207K 0.02%
+4,537
New +$208K
GSAT icon
184
CALL
Globalstar
GSAT
$10.7B
$200K 0.02%
+3,133
New +$161K
ESPR
185
DELISTED
Esperion Therapeutics
ESPR
$197K 0.02%
12,444
-8,056
-39% -$116K
FLEX icon
186
Flex
FLEX
$45.9B
$196K 0.02%
+23,525
New +$177K
ENTR
187
DELISTED
ENTROPIC COMMUNICATIONS INC COM STK (DE)
ENTR
$190K 0.02%
+57,140
New +$201K
ARCT icon
188
PUT
Arcturus Therapeutics
ARCT
$224M
$178K 0.02%
+1,471
New +$178K
AFFX
189
DELISTED
Affymetrix Inc
AFFX
$157K 0.02%
17,618
-25,691
-59% -$204K
VSH icon
190
Vishay Intertechnology
VSH
$5.11B
$156K 0.02%
+10,054
New +$149K
EMKR
191
DELISTED
Emcore Corp
EMKR
$146K 0.02%
+3,541
New +$155K
SMA
192
DELISTED
SYMMETRY MEDICAL INC
SMA
$125K 0.01%
+14,107
New +$123K
TGTX icon
193
TG Therapeutics
TGTX
$7.34B
$121K 0.01%
+12,850
New +$82.2K
GYRE icon
194
Gyre Therapeutics
GYRE
$693M
$99K 0.01%
+28
New +$91.4K
ACHV icon
195
CALL
Achieve Life Sciences
ACHV
$743M
– –
-27
Closed -$706K
ARAY icon
196
Accuray
ARAY
$32.8M
– –
-14,952
Closed -$144K
BMY icon
197
Bristol-Myers Squibb
BMY
$132B
– –
-103,301
Closed -$5.37M
BMY icon
198
PUT
Bristol-Myers Squibb
BMY
$132B
– –
-260,700
Closed -$13.5M
C icon
199
Citigroup
C
$233B
– –
-132,346
Closed -$6.3M
CAPL icon
200
CrossAmerica Partners
CAPL
$887M
– –
-150,729
Closed -$4.06M
6 7
8
9 10

Similar funds

B
BancorpSouth Tupelo, Mississippi $1.01B AUM 4.88% 1-Year Est. Return
GLRA
Gerald L. Ray & Associates Dallas, Texas $802M AUM 21.01% 1-Year Est. Return
KRC
Kingdom Ridge Capital White Plains, New York $750M AUM 34.23% 1-Year Est. Return
GS
GAM Systematic Cambridge, United Kingdom $696M AUM 28.4% 1-Year Est. Return
JPCCM
J&P (China) Capital Management Hong Kong, China $586M AUM 82.64% 1-Year Est. Return
NBC
Neuberger Berman Canada Toronto, Ontario, Canada $542M AUM 14.17% 1-Year Est. Return
NTC
North Tide Capital Boston, Massachusetts $469M AUM 6.57% 1-Year Est. Return
SD
Sumway Development Shanghai, China $427M AUM 43.82% 1-Year Est. Return

Pacific Alternative Asset Management Company (PAAMCO)'s Q2 2014 Portfolio in Review

As of Q2 2014, Pacific Alternative Asset Management Company (PAAMCO) held 253 positions worth $842M, up 45% from $579M the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Pacific Alternative Asset Management Company (PAAMCO) deployed $202M of net new capital in Q2 2014, opening 95 new positions and adding to 71 existing holdings. Its largest new stake was Cigna: 166,218 shares worth $15.3M.

By sector, the portfolio is most concentrated in Healthcare at 37% of assets, up from 29% a quarter earlier, followed by Technology and Communication Services.

On the sell side, the largest reduction was McKesson, an estimated $12.7M trimmed.

  • Pacific Alternative Asset Management Company (PAAMCO)'s largest Q2 2014 buy was Cigna: 166,218 shares worth $15.3M.
  • Pacific Alternative Asset Management Company (PAAMCO) added most to FOREST LABORATORIES INC in Q2 2014, an estimated $46.2M increase.
  • Pacific Alternative Asset Management Company (PAAMCO)'s biggest Q2 2014 reduction was McKesson, cutting an estimated $12.7M.
  • Pacific Alternative Asset Management Company (PAAMCO) fully exited Express Scripts Holding Company in Q2 2014, selling an estimated $7.6M.
  • Pacific Alternative Asset Management Company (PAAMCO)'s ten largest holdings make up 35% of its $842M portfolio in Q2 2014.
  • Pacific Alternative Asset Management Company (PAAMCO) opened 95 new positions and closed 59 in Q2 2014.
  • Pacific Alternative Asset Management Company (PAAMCO)'s portfolio value rose 45% quarter-over-quarter to $842M.

Based on Pacific Alternative Asset Management Company (PAAMCO)'s 13F filing for Q2 2014, filed 12 Aug 2014.